📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

UPDATE 1-Ansell sells condom division to Chinese consortium for $600 mln

Published 25/05/2017, 09:08 am
UPDATE 1-Ansell sells condom division to Chinese consortium for $600 mln
ANN
-
600079
-

(Adds details of sales process, chairman comment)

SYDNEY, May 25 (Reuters) - Rubber products maker Ansell Ltd ANN.AX said on Thursday it would sell its condom business to a Chinese consortium for $600 million, leading the Australian company to launch a $265 million on-market share buyback.

China's Humanwell Healthcare Group Co Ltd 600079.SS and CITIC Capital China Partners have bought the division, which also includes a lubricant and devices business, Ansell said.

"We are delighted with this outcome, following a thorough and competitive process, which realises significant value for Ansell shareholders," Ansell Chief Executive Magnus Nicolin said in a statement.

Ansell in February said several parties had expressed interest in the division, which sent its shares soaring at the time. company expects to receive net after-tax proceeds of $529 million from the sale. The share buyback announced on Thursday represents 10 percent of shares on issue.

Chairman Glenn Barnes said Ansell, whose main business is making gloves for factories and medical applications, would also consider making value accretive acquisitions that could generate attractive returns.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.